期刊文献+

研究开发中的海洋抗癌活性物质 被引量:1

Progress on Marine Anticancer Drugs in R&D
下载PDF
导出
摘要 海洋天然产物现已成为临床抗癌药物的重要来源,从didemmine B开始,进入临床研究的抗癌活性物质已经有二十多种。根据海洋来源抗癌活性物质的作用靶点不同,系统综述了正在研究中的十几种来源于海洋的天然抗癌活性物质的作用机制和研究开发情况等。 Marine natural products are a kind of very important pool of anticancer drugs in clinic. Since the first marine-source anticancer didemmine B was found, more than twenty marine natural products have been tested in preclinical trials and in phase Ⅰ to Ⅲ clinical trials, and a few of them have been withdrawn from the clinical trials. According to their acting targets, this paper introduces these marine-source anticancer drugs separately.
出处 《药学进展》 CAS 2006年第10期433-442,共10页 Progress in Pharmaceutical Sciences
关键词 海洋 天然产物 抗癌 作用机制 Marine Natural products Anticancer Mechanism of effect
  • 相关文献

参考文献65

  • 1Newman D J,Cragg G M,Snader K M.Natural products as sources of new drugs over the period 1981-2002[J].J Nat Prod,2003,66(7):1022-1037.
  • 2Blunt J W,Copp B R,Prinsep M R,et al.Marine natural products[J].Nat Prod Rep,2006,23(1),26-78.
  • 3Bergmann W,Burke D C.Contributions to the study of marine products[J].J Org Chem,1955,20(11):1501-1507.
  • 4ter Haar E,Kowalski R J,Hamel E,et al.Discodermolide,a cytotoxic marine agent that stabilizes microtubules more potently than taxol[J].Biochemistry,1996,35(1):243-250.
  • 5Smith A B,Kaufman M D,Arimoto H,et al.Gram-scale synthesis of (+)-discodermolide[J].Org Lett,1999,1(11):1823-1826.
  • 6Martello L A,Lamarche M J,Horwitz S B,et al.The rela-tionship between Taxol and (+)-discodermolide:synthetic analogs and modeling studies[J].Chem Biol,2001,8(9):843-855.
  • 7Huang G S,Lopez-Barcons L,McDaid H M,et al.Potentiation of Taxol efficacy by discodermolide in ovarian carcinoma xenograft-bearing mice[J].Clin Cancer Res,2006,12(1):298-304.
  • 8Honore S,Kamath K,Jordan M A,et al.Suppression of microtubule dynamics by discodermolide by a novel mechanism is associated with mitotic arrest and inhibition of tumor cell proliferation[J].Mol Cancer Ther,2003 2(12):1303-1311.
  • 9Beck F W,Eilender D S,Mohammad R M,et al.Factors affecting bryostatin 1-enhanced 2-CdA cytotoxicity in resistant B-cell chronic lymphocytic leukemiaInt.[J].Int J Mol Med,2004,14(1):113-119.
  • 10Garteiz D A,Madden T,Newman A,et al.Quantitation of dolastatin-10 using HPLC/electrospray ionization mass spectrometry:application in a phase Ⅰ clinical trial[J].Cancer Chemother Pharmacol,1998,41(4):299-306.

同被引文献11

引证文献1

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部